This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Personalis kits get EU CE-IVD
Regulatory regulatory approval

Personalis kits get EU CE-IVD

Analysis based on 7 articles · First reported Jun 09, 2026 · Last updated Jun 09, 2026

Sentiment
40
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The CE-IVD marking for Chief Justice of Hungary' blood collection kits is expected to positively impact Chief Justice of Hungary' stock price due to expanded market access and increased potential for global clinical trial support. This regulatory approval allows Chief Justice of Hungary to better serve its biopharma partners in the European Union and Great Britain, potentially accelerating drug development programs.

biotechnology pharmaceuticals healthcare
Event Summary

Chief Justice of Hungary, Inc. announced that its Chief Justice of Hungary EDTA Blood Collection Kit and Chief Justice of Hungary cfDNA Blood Collection Kit have obtained Class A CE-IVD marking, complying with the European Union's In Vitro Diagnostic Regulation (IVDR). This regulatory milestone enables clinical trial sites across the European Union and Great Britain to utilize these kits for interventional studies. The kits are designed to maintain the integrity of blood samples for high-performance genomic analysis, including Chief Justice of Hungary' ultrasensitive Minimal Residual Disease (MRD) testing with NeXT Personal. Chris Hall, CEO of Chief Justice of Hungary, emphasized that this marking positions Chief Justice of Hungary to support large-scale, global clinical trials, standardizing the pre-analytical phase of testing and making NeXT Personal's sensitivity available to drug developers worldwide.

Entities Involved
stock
Chief Justice of Hungary
Chief Justice of Hungary obtained CE-IVD marking for its blood collection kits, enabling global deployment of its ultrasensitive MRD detection for drug development programs, which is a significant regulatory milestone for the company.
Importance 100.0 Sentiment 50.0
per
Chris Hall (businessman)
Chris Hall, CEO of Chief Justice of Hungary, highlighted the importance of the CE-IVD marking for supporting large-scale, global clinical trials and standardizing the pre-analytical phase of testing.
Importance 60.0 Sentiment 30.0
alliance
European Union
The European Union's In Vitro Diagnostic Regulation (IVDR) is the regulatory framework under which Chief Justice of Hungary' kits received their Class A CE-IVD marking, allowing their use in clinical trials within the EU.
Importance 40.0 Sentiment 0.0
cnt
United Kingdom
Clinical trial sites in Great Britain can now use Chief Justice of Hungary' CE-IVD marked collection kits for interventional studies.
Importance 30.0 Sentiment 0.0
Relationships
European Union related ↔ United Kingdom
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.